Exercise Intolerance

Cardiology Clinics

Volumn 29, Issue 3, 2011, Pages 461-477

  Kitzman, Dalane W ^a   Groban, Leanne ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Diastolic heart failure; Heart rate; Hypertrophic cardiomyopathy; Systolic heart failure

Indexed keywords

ALAGEBRIUM; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIURETIC AGENT; CANDESARTAN; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO; SPIRONOLACTONE; VERAPAMIL;

BICYCLE; BLOOD GAS ANALYSIS; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RESPONSE; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; EXERCISE INTOLERANCE; EXERCISE PHYSIOLOGY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR SYSTEM; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; TREADMILL EXERCISE;

EID: 79960751466     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2011.06.002     Document Type: Review

References (113)

1. Gandhi S.K., Powers J.E., Fowle K.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2000, 344(1):17-22.
2. Powers J.E., Gandhi S.K., Kramer R.K., et al. Predictors of poor outcome in patients with hypertensive pulmonary edema. J Am Coll Cardiol 2004, 43(5A):227A. [abstract].
3. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288(17):2144-2150.
4. Bol E., de Vries W.R., Mosterd W.L., et al. Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure. Int J Cardiol 2000, 72:255-263.
5. Jones R.C., Francis G.S., Lauer M.S. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004, 44(5):1025-1029.
6. Francis D.P., Shamin W., Davies L.C., et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2 slope and peak VO2. Eur Heart J 2000, 21:154-161.
7. Moore B., Brubaker P.H., Stewart K.P., et al. VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls. J Card Fail 2007, 13(4):259-262.
8. Maldonado-Martin S., Brubaker P.H., Kaminsky L.A., et al. The relationship of a 6-min walk to VO(2 peak) and VT in older heart failure patients. Med Sci Sports Exerc 2006, 38(6):1047-1053.
9. Higginbotham M.B., Morris K.G., Williams R.S., et al. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 1986, 58:281-291.
10. Higginbotham M.B., Morris K.G., Williams R.S., et al. Physiologic basis for the age-related decline in aerobic work capacity. Am J Cardiol 1986, 57:1374-1379.
11. Sullivan M., Knight J.D., Higginbotham M.B., et al. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure: muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989, 80:769-781.
12. Higginbotham M.B., Sullivan M., Coleman R.E., et al. Regulation of stroke volume during exercise in patients with severe left ventricular dysfunction: importance of Starling mechanism. J Am Coll Cardiol 1987, 9:58A.
13. Kitzman D.W., Sullivan M., Cobb F.R., et al. Exercise cardiac output declines with advancing age in normal subjects. J Am Coll Cardiol 1989, 13(2):241A.
14. Sullivan M., Cobb F.R., Knight J.D., et al. Stroke volume increases by similar mechanisms in men and women. Am J Cardiol 1991, 67:1405-1412.
15. Kitzman D.W., Higginbotham M.B., Cobb F.R., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065-1072.
16. Sullivan M., Higginbotham M.B., Cobb F.R. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988, 77:552-559.
17. Sullivan M., Higginbotham M.B., Cobb F.R. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989, 79:324-329.
18. Sullivan M., Cobb F.R. Central hemodynamic response to exercise in patients with chronic heart failure. Chest 1992, 101:340S-346S.
19. Nagueh S.F., Middleton K.J., Kopelen H.A., et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30(6):1527-1533.
20. Ommen S.R., Nishimura R.A., Appleton C.P., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000, 102(15):1788-1794.
21. Hadano Y., Murata K., Yamamoto T., et al. Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function. Am J Cardiol 2006, 97(7):1025-1028.
22. Skaluba S.J., Litwin S.E. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004, 109(8):972-977.
23. Ha J.W., Oh J.K., Pellikka P.A., et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. J Am Soc Echocardiogr 2005, 18(1):63-68.
24. Kitzman D.W., Sullivan M. Exercise intolerance in patients with heart failure: role of diastolic dysfunction. Diastolic relaxation of the heart 1994, 295-302. Kluwer Academic Publishers, Boston. W. Grossman (Ed.).
25. Brubaker P.H., Joo K.C., Stewart K.P., et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 2006, 26(2):86-89.
26. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20):2138-2147.
27. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Cardiovascular Health Study Research Group. Am J Cardiol 2001, 87(4):413-419.
28. Iriarte M., Murga N., Morillas M., et al. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 1993, 71:308-312.
29. Iriarte M.M., Perez O.J., Sagastagoitia D., et al. Congestive heart failure due to hypertensive ventricular diastolic dysfunction. Am J Cardiol 1995, 76(13):43D-47D.
30. Little W.C. Enhanced load dependence of relaxation in heart failure: clinical implications. Circulation 1992, 85(6):2326-2328.
31. Gelpi R.J. Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs. Circ Res 1991, 68:555-567.
32. Shannon R.P., Komamura K., Gelpi R.J., et al. Altered load: an important component of impaired diastolic function in hypertension and heart failure. Diastolic relaxation of the heart 1994, 177-185. Kluwer Academic Publishers, Norwell (MA). B.H. Lorell, W. Grossman (Eds.).
33. Little W.C., Braunwald E. Assessment of cardiac performance. Heart disease 1996, 421-444. W.B. Saunders Company, Philadelphia. E. Braunwald (Ed.).
34. Hoit B.D., Walsh R.A. Diastolic dysfunction in hypertensive heart disease. Left ventricular diastolic dysfunction and heart failure 1994, 354-372. Lea & Febiger, Philadelphia. W.H. Gaasch, M.M. LeWinter (Eds.).
35. Little W.C., Ohno M., Kitzman D.W., et al. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995, 92:1933-1939.
36. Lakatta E. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999, 47:613-625.
37. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107(1):139-146.
38. Hundley W.G., Kitzman D.W., Morgan T.M., et al. Cardiac cycle dependent changes in aortic area and aortic distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001, 38(3):796-802.
39. Rerkpattanapipat P., Hundley W.G., Link K.M., et al. Relation of aortic distensibility determine by magnetic resonance imaging in patients = 60 years of age to systolic heart failure and exercise capacity. Am J Cardiol 2002, 90(11):1221-1225.
40. Drexler H., Hayoz D., Monzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992, 69:1596-1601.
41. Hayoz D., Drexler H., Munzel T., et al. Flow-mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993, 87:VII-92-VII-96.
42. Hornig B., Maier V., Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996, 93(2):210-214.
43. Hornig B., Arakawa N., Haussmann D., et al. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998, 98(25):2842-2848.
44. Hundley W.G., Bayram E., Hamilton C.A., et al. Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am J Physiol Heart Circ Physiol 2007, 292(3):H1427-H1434.
45. Myers J., Froelicher V. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med 1991, 115:377-386.
46. Franciosa J.A. Role of ventricular function in determining exercise capacity in patients with chronic left ventricular failure. Adv Cardiol 1986, 34:170-178.
47. Wilson J.R., Rayos G., Yeoh T.K., et al. Dissociation between exertional symptoms and circulatory function in patients with heart failure. Circulation 1995, 92(1):47-53. Ref Type: Journal (Full).
48. Clark A.L., Sparrow J.L., Coats A.J. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin?. Eur Heart J 1995, 16(1):49-52.
49. Fink L.I., Wilson J.R., Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1966, 57:249-253.
50. Sullivan M., Cobb F.R. The anaerobic threshold in chronic heart failure. Circulation 1990, 81:II-47-II-58.
51. Green H.J. Manifestations and sites of neuromuscular fatigue. Biochem Exercise 1990, VII:13-35.
52. Brucks S., Little W.C., Chao T., et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004, 93(8):1055-1057.
53. Deedwania P.C., Gottlieb S., Ghali J.K., et al. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004, 25(15):1300-1309.
54. Sanders P., Kistler P.M., Morton J.B., et al. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation 2004, 110(8):897-903.
55. Nagaya N., Moriya J., Yasumura Y., et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110(24):3674-3679.
56. Sullivan J.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81:518-527.
57. Adamopoulos S., Coats A., Brunotte F., et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993, 21:1101-1106.
58. Stratton J., Dunn J.F., Adamopoulos S., et al. Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure. J Appl Physiol 1994, 76:1575-1582.
59. Kouba E.J., Hundley W.G., Brubaker P.H., et al. Skeletal muscle remodeling and exercise intolerance in elderly patients with diastolic heart failure. Am J Geriatr Cardiol 2003, 12(2):135. [abstract].
60. Felker G.M., Adams K.F., Gattis W.A., et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 2004, 44(5):959-966.
61. Adams V., Jiang H., Yu J., et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 1999, 33(4):959-965.
62. Wilson J.R., Fink L., Maris J., et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985, 71(1):57-62.
63. Minotti J.R., Johnson E.C., Hudson T.L., et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990, 86:751-758.
64. Minotti J.R., Christoph I., Oka R., et al. Impaired skeletal muscle function in patients with congestive heart failure. J Clin Invest 1991, 88:2077-2082.
65. Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992, 85:1364-1373.
66. Minotti J.R., Christoph I., Massie B.M. Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure. Chest 1992, 101:333S-339S.
67. Wilson J.R., Mancini D.M. Skeletal muscle metabolic dysfunction. Implications for exercise intolerance in heart failure. Circulation 1993, 87:VII-104-VII-109.
68. Minotti J.R., Pillay P., Oka R., et al. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993, 75(1):373-381.
69. Kao W., Helpern J.A., Goldstein S., et al. Abnormalities of skeletal muscle metabolism during nerve stimulation determined by 31P nuclear magnetic resonance spectroscopy in severe congestive heart failure. Am J Cardiol 1995, 76(8):606-609.
70. Lang C.C., Chomsky D.B., Rayos G., et al. Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure. J Appl Physiol 1997, 82:257-261.
71. Harrington D., Anker S.D., Chua T.P., et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997, 30(7):1758-1764.
72. Peters D.G., Mitchell H.L., McCune S.A., et al. Skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase gene expression in congestive heart failure. Circ Res 1997, 81(5):703-710.
73. Vescovo G., Volterrani M., Zennaro R., et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 2000, 84(4):431-437. [see comments].
74. Grimby G. Physical activity and effects of muscle training in the elderly. Ann Clin Res 1988, 20:62-66.
75. Fleg J.L., Lakatta E.G. Role of muscle loss in the age-associated reduction in VO2 max. J Appl Physiol 1988, 65(3):1147-1151.
76. Rice C.L., Cunningham D.A., Paterson D.H., et al. Arm and leg composition determined by computed tomography in young and elderly men. Clin Physiol 1989, 9(3):207-220.
77. Kallman D.A., Plato C.C., Tobin J.D. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol 1990, 45:M82-M88.
78. Buchner D., deLateur B. The importance of skeletal muscle strength to physical function in older adults. Ann Behav Med 1991, 13:4206-4214.
79. Menshikova E.V., Ritov V.B., Toledo F.G.S., et al. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 2005, 288(4):E818-E825.
80. Warner J.G., Metzger C., Kitzman D.W., et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567-1572.
81. Aronow W.S., Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993, 71:602-604.
82. Vandenberg V.F., Rath L.S., Stuhlmuller P., et al. Estimation of left ventricular cavity area with on-line, semiautomated echocardiographic edge detection system. Circulation 1992, 86:159-166.
83. Bonow R.O., Leon M.B., Rosing D.R., et al. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 1981, 65:1337-1350.
84. Bonow R.O., Dilsizian V., Rosing D.R., et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985, 72:853-864.
85. Udelson J., Bonow R.O. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy. Left ventricular diastolic dysfunction and heart failure 1996, 465-489. Lea & Febiger, Malvern, Pennsylvania. W.H. Gaasch (Ed.).
86. Chen C.H., Nakayama M., Talbot M., et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. J Am Coll Cardiol 1999, 33:1602-1609.
87. Serizawa T., Shin-Ichi M., Nagai Y., et al. Diastolic abnormalities in low-flow and pacing tachycardia-induced ischemia in isolated rat hearts-modification by calcium antagonists. Diastolic relaxation of the heart 1996, 266-274. Kluwer Academic Publishers, Norwell (MA). B.H. Lorell, W. Grossman (Eds.).
88. Cheng C.P., Pettersson K., Little W.C. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure. J Pharma and Exper Thera 1994, 271:1409-1417.
89. Cheng C.P., Noda T., Ohno M., et al. Differential effects of enalaprilat and felodipine on diastolic function during exercise in dogs with congestive heart failure. Circulation 1993, 88(4):I-294. [abstract].
90. Little W.C., Cheng C.P., Elvelin L., et al. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. Cardiovasc Drugs Ther 1995, 9(5):657-663.
91. Ten Cate F.J., Serruys P.W., Mey S., et al. Effects of short-term administration of verapamil on left ventricular filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation 1983, 68(6):1274-1279.
92. Hess O.M., Murakami T., Krayenbuehl H.P. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?. Circulation 1996, 74:530-543.
93. Brutsaert D.L., Rademakers F., Sys S.U., et al. Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis 1985, 28:143-163.
94. Brutsaert D.L., Sys S.U., Gillebert T.C. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993, 22:318-325.
95. Setaro J.F., Zaret B.L., Schulman D.S., et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66:981-986.
96. Little W.C., Wesley-Farrington D.J., Hoyle J., et al. Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction. J Cardiovasc Pharmacol 2004, 43(2):288-293.
97. Little W.C., Zile M.R., Klein A.L., et al. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and diastolic dysfunction. Am J Cardiol 2006, 98(3):383-385.
98. Pitt B., Reichek N., Willenbrock R., et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 2003, 108(15):1831-1838.
99. Rajagopalan S., Pitt B. Aldosterone as a target in congestive heart failure. Med Clin North Am 2003, 87(2):441-457.
100. Zannad F., Alla F., Dousset B., et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized Aldactone evaluation study (RALES). Rales Investigators. Circulation 2000, 102(22):2700-2706.
101. Daniel K.R., Wells G.L., Fray B., et al. The effect of spironolactone on exercise tolerance and quality of life in elderly women with diastolic heart failure. Am J Geriatr Cardiol 2003, 12(2):131. [abstract].
102. Mottram P.M., Haluska B., Leano R., et al. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004, 110(5):558-565.
103. Little W.C., Zile M.R., Kitzman D.W., et al. The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 2005, 11(3):191-195.
104. Kass D.A., Chen C.H., Talbot M.W., et al. Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration. Circulation 1999, 100(8):807-812.
105. Packer M., Carver J.R., Chesebro J., et al. Effect of oral milrinone on mortality in severe chronic heart failure: The Prospective Randomized Milrinone Survival Evaluation (PROMISE). N Engl J Med 1991, 325:1468-1475.
106. Creager M.A., Massie B.M., Faxon D.P., et al. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol 1985, 6(1):163-173.
107. Sullivan M. Role of exercise conditioning in patients with severe systolic left ventricular dysfunction. Cardiovascular response to exercise 1994, 359-372. Futura Publishing Company, Mount Kisco. G.F. Fletcher (Ed.).
108. Vaitkevicius P.V., Fleg J., Engel J.H., et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993, 88(5):1456-1462.
109. Pina I.L., Apstein C.S., Balady G.J., et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003, 107(8):1210-1225.
110. Coats A., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure. Circulation 1992, 85:2119-2131.
111. Arbab-Zadeh A., Dijk E., Prasad A., et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004, 110(13):1799-1805.
112. Kitzman D.W., Brubaker P.H., Abdelahmed A., et al. Effect of exercise training on exercise capacity, quality of life, and flow-mediated arterial dilation in elderly patients with diastolic heart failure. J Am Coll Cardiol 2004, 110(17):III-558. [abstract].
113. Smart N., Haluska B., Jeffriess L., et al. Exercise training in systolic and diastolic dysfunction: effects on cardiac function, functional capacity, and quality of life. Am Heart J 2007, 153(4):530-536.